Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galapagos NV (NASDAQ:GLPG)

52.83
Delayed Data
As of 2:22pm ET
 -0.07 / -0.13%
Today’s Change
37.03
Today|||52-Week Range
65.70
-15.98%
Year-to-Date
Don't Give Up On Gilead Sciences
Jul 18 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close52.90
Today’s open52.43
Day’s range52.18 - 52.87
Volume32,059
Average volume (3 months)68,470
Market cap$2.1B
Dividend yield--
Data as of 2:22pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)-143.26%
Earnings growth (this year)--
Earnings growth (next 5 years)-77.90%
Revenue growth (last year)-52.36%
P/E ratio--
Price/Sales51.41
Price/Book5.21

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.14-0.98%
GWPHGW Pharmaceuticals P...-1.48-1.56%
RAREUltragenyx Pharmaceu...+0.61+1.14%
IPXLImpax Laboratories I...+0.37+1.22%
Data as of 2:45pm ET, 07/25/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$43.7M
Annual profit (last year)-$130.7M
Net profit margin-299.29%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Onno van de Stolpe
Chief Financial Officer
Bart Filius
Corporate headquarters
Mechelen, Brussels Region

Forecasts

Partner Offers

Search for Jobs